A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Cidara Therapeutics Inc’s current trading price is -27.70% away from its 52-week high, while its distance from the 52-week low is 80.44%. The stock’s price range for this time frame has been between $0.59 and $1.48. The trading volume of the company’s shares in the Healthcare reached around 1.42 million for the day, which was evidently higher than the average daily volume of 0.56 million over the last three months.
In terms of market performance, Cidara Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $1.48 on 05/23/23, while the lowest value was $0.59 on 11/17/23.
How Financial Performance Impacts Market Capitalization
Cidara Therapeutics Inc (CDTX) has experienced a quarterly rise of 34.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 96.96M.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7370, with a change in price of +0.2700. Similarly, Cidara Therapeutics Inc recorded 635,616 in trading volume during the last 100 days, posting a change of +33.75%.
How CDTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CDTX stands at 0.54. Similarly, the long-term debt-to-equity ratio is also 0.41.
CDTX Stock Stochastic Average
The raw stochastic average for Cidara Therapeutics Inc over the last 50 days is presently at 95.70%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 95.56%. Further, the company’s Stochastic %K and %D values for the last 20 days were 91.51% and 90.39%, respectively.
CDTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 34.76% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 13.56%. Over the past 30 days, the price of CDTX has fallen by 50.24%. And in the last five days, it has surged by 43.35%.
